Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF.
Clinical trial NCT02909166 · UNKNOWN
Trial details
- NCT number
- NCT02909166
- Sponsor
- Mika Lehto
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2016-12-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.